Latest papers

The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia

Alkaloid synthesis and accumulation in Leucojum aestivum in vitro cultures.

An unusual case of nightmares with galantamine.

Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.

Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons

Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils

Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.

Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.

Optimized nutrient medium for galanthamine production in Leucojum aestivum L. in vitro shoot system.

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.

[Galantamine (reminyl) in the treatment of severe Alzheimer's disease]

A Single in Vivo Application of Cholinesterase Inhibitors Has Neuron Type-Specific Effects on Nicotinic Receptor Activity in Guinea Pig Hippocampus

Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.

Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*.

Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I

[Bradycardia induced by galantamine].

Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor.